INHC — Induction Healthcare Income Statement
0.000.00%
- £8.93m
- £5.83m
- £13.65m
- 48
- 58
- 53
- 51
Annual income statement for Induction Healthcare, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2020 March 31st | C2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.148 | 1.36 | 7.23 | 12.9 | 13.6 |
Cost of Revenue | |||||
Gross Profit | 0.075 | 0.725 | 4.48 | 8.13 | 10.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.72 | 9.38 | 16.4 | 30.3 | 17.9 |
Operating Profit | -3.57 | -8.02 | -9.13 | -17.4 | -4.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.53 | -8.12 | -9.16 | -17.4 | -4.21 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.53 | -7.61 | -8.08 | -16.6 | -3.25 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -3.53 | -7.61 | -8.43 | -17.4 | -3.26 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.53 | -7.61 | -8.43 | -17.4 | -3.26 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.116 | -0.176 | -0.101 | -0.125 | -0.035 |